Press release
Pranlukast Market Expected to Hit USD 2.58 Billion by 2032 with a Remarkable 4.18% CAGR
Pranlukast Market: Rising Demand for Anti-Asthmatic Therapies Drives Growth in Allergy Treatment Segment. The Pranlukast Market is gaining attention within the global pharmaceutical industry, especially as respiratory disorders like asthma and allergic rhinitis continue to affect millions of people worldwide. Pranlukast, a leukotriene receptor antagonist, is commonly prescribed as an anti-inflammatory agent to manage chronic asthma and seasonal allergies, particularly in pediatric and adult populations who are unresponsive to corticosteroids alone.Market Overview
Pranlukast belongs to a class of anti-asthmatic medications that works by blocking leukotrienes, inflammatory chemicals involved in the pathophysiology of asthma and allergic conditions. While widely used in several Asian countries including Japan and South Korea, the drug is increasingly being explored in new markets for its efficacy, safety profile, and role in combination therapies.
Growing awareness about asthma management, coupled with the increasing demand for personalized medicine and long-term respiratory care, is contributing to the gradual expansion of the Pranlukast market across developing and emerging economies.
As per MRFR analysis, the Pranlukast Market Size was estimated at 1.68 (USD Billion) in 2023.The Pranlukast Industry is expected to grow from 1.78(USD Billion) in 2024 to 2.58 (USD Billion) by 2032. The Pranlukast Market CAGR (growth rate) is expected to be around 4.18% during the forecast period (2024 - 2032).
Request Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart :
https://www.marketresearchfuture.com/sample_request/27136
Market Growth
The Pranlukast market is projected to grow steadily over the coming years, supported by:
• Rising prevalence of asthma, particularly in urban populations and children
• Increased access to generic and branded formulations in Asia-Pacific and Latin America
• Growing emphasis on maintenance therapies for chronic respiratory diseases
Expansion of online pharmacies and telemedicine
boosting prescription rates in rural and semi-urban areas
Moreover, pharmaceutical companies are investing in clinical trials to explore Pranlukast's potential beyond asthma treatment, including applications in atopic dermatitis and inflammatory bowel disease, further expanding its market scope.
Key Companies in the Pranlukast Market Include:
• Intas Pharmaceuticals Ltd.
• Mylan N.V.
• Cadila Healthcare Limited
• Teva Pharmaceutical Industries Ltd.
• Ipca Laboratories Ltd.
• Sandoz International GmbH
• Emcure Pharmaceuticals Ltd.
• Torrent Pharma
• Glenmark Pharmaceuticals Ltd.
• Torrent Pharmaceuticals Ltd.
• AstraZeneca
• Cipla Ltd.
• Dr. Reddy's Laboratories Ltd.
• Aurobindo Pharma Limited
• Lupin
Market Dynamics
Key Drivers
• High global burden of respiratory disorders: Asthma affects over 250 million people globally, creating consistent demand for bronchodilator and leukotriene-modifying agents.
• Preference for oral therapies: Pranlukast's oral administration makes it preferable for long-term use, especially in pediatric care.
• Generic availability: Generic drug manufacturers are entering the market, making treatment more affordable and accessible.
Challenges
• Limited approval in Western markets: Pranlukast is not yet approved in the US and many parts of Europe, which restricts global adoption.
• Competition from alternative therapies: Drugs like montelukast dominate many regions, posing a challenge to market penetration.
• Side-effect concerns: Though generally well-tolerated, some leukotriene antagonists have been linked to neuropsychiatric side effects, affecting physician prescribing habits.
Direct Purchase this Research Report: https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=27136
Pranlukast Market Segmentation
• Pranlukast Treatment Type Outlook
• Asthma
Chronic Obstructive Pulmonary Disease (COPD)
• Pranlukast Drug Formulation Outlook
• Tablets
• Suspension
• Inhalers
Pranlukast Distribution Channel Outlook
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Pranlukast Dose Strength Outlook
• 75 mg
• 150 mg
• 300 mg
Pranlukast Regional Outlook
• North America
• Europe
• South America
• Asia Pacific
• Middle East and Africa
Future Outlook
The global Pranlukast market is expected to witness moderate but consistent growth through 2032. Market expansion is likely to be strongest in Asia-Pacific, where the drug is already established, with new growth opportunities in Latin America, Africa, and Eastern Europe due to increasing healthcare investments and awareness.
Comprehensive Overview: https://www.marketresearchfuture.com/reports/pranlukast-market-27136
Future growth will also depend on:
• Regulatory approvals in new geographies
• Innovative fixed-dose combinations with inhaled corticosteroids
• Research into additional indications, broadening its clinical utility
• Digital health tools enhancing prescription and patient compliance
Reasons to Buy the Pranlukast Market Report
✔️ In-depth analysis of market size, forecast, and competitive landscape
✔️ Insights into regional growth patterns and market accessibility
✔️ Assessment of key players, generic drug opportunities, and pipeline developments
✔️ Evaluation of emerging therapeutic applications for pranlukast beyond asthma
✔️ Strategic guidance for pharmaceutical firms, distributors, and investors entering respiratory care markets
The Pranlukast Market presents promising opportunities in respiratory and allergy therapeutics, especially in underserved regions. With a growing focus on long-term asthma control and generic drug expansion, stakeholders who invest early in this segment stand to benefit from consistent demand and innovation in the years ahead.
FAQs
What is driving the growth of the Pranlukast market?
Which regions dominate the Pranlukast market?
What are the main challenges facing the Pranlukast market?
What are the potential growth opportunities for Pranlukast in the future?
Who are the major players in the Pranlukast market?
Related Reports
AI in Medical Writing Market: https://www.marketresearchfuture.com/reports/ai-medical-writing-market-31280
Artificial Intelligence In Animal Health Market: https://www.marketresearchfuture.com/reports/artificial-intelligence-animal-health-market-31244
Acute Wound Care Market: https://www.marketresearchfuture.com/reports/acute-wound-care-market-8844
Pharma Social Media Market: https://www.marketresearchfuture.com/reports/pharma-social-media-market-32048
Bone Void Fillers Market: https://www.marketresearchfuture.com/reports/bone-void-filler-market-32038
Healthcare Interoperability Solution Market: https://www.marketresearchfuture.com/reports/healthcare-interoperability-solution-market-31976
Chiropractic Care Market: https://www.marketresearchfuture.com/reports/chiropractic-care-market-32293
Clinical Trial Supplies Market: https://www.marketresearchfuture.com/reports/clinical-trial-supplies-market-9183
Colorectal Cancer Screening Market: https://www.marketresearchfuture.com/reports/colorectal-cancer-screening-market-9203
Dental Cements Market: https://www.marketresearchfuture.com/reports/dental-cement-market-9274
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. MRFR's approach combines the proprietary information with various data sources to give an extensive understanding to the client about the latest key developments, expected events and also about what action to take based on these aspects.
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pranlukast Market Expected to Hit USD 2.58 Billion by 2032 with a Remarkable 4.18% CAGR here
News-ID: 4104910 • Views: …
More Releases from Market Research Future
Digitally Printed Wallpaper Market Size estimated at USD 6.5 Billion in 2024 and …
The digitally printed wallpaper market is experiencing a significant transformation, driven by advancements in technology, changing consumer preferences, and a growing emphasis on sustainability. As of 2024, the market was valued at approximately $6.5 billion, and it is projected to grow to $40.9 billion by 2035, with a compound annual growth rate (CAGR) of 18.2% from 2025 to 2035. This article explores the key trends, drivers, and future outlook of…
Glue Laminated Timber Market outlook shows steady growth from USD 3.508 Billion …
The construction industry is undergoing a significant transformation, driven by the increasing demand for sustainable building materials. Among these materials, glue laminated timber (glulam) has emerged as a frontrunner, offering a combination of strength, versatility, and environmental benefits. The Glue Laminated Timber Market is projected to grow from $3.41 billion in 2024 to $4.661 billion by 2035, with a compound annual growth rate (CAGR) of 2.88% during the forecast period…
Fiber Cement Board Market Size and future outlook project industry expansion fro …
The fiber cement board market is experiencing significant growth, driven by increasing demand for sustainable building materials and advancements in construction technologies. This article explores the key trends, market dynamics, and future outlook for the fiber cement board industry.
Overview of the Fiber Cement Board Market
According to the latest analysis by Market Research Future, the fiber cement board market was valued at approximately USD 14446.52 million in 2024 and is projected…
Plastic Pipes Industry Market Size highlights consistent growth from USD 26.25 B …
The plastic pipes market is experiencing significant growth, driven by various factors including urbanization, sustainability initiatives, and technological advancements. As of 2024, the market size is estimated at $26.25 billion, with projections indicating it could reach $44.9 billion by 2035, growing at a compound annual growth rate (CAGR) of 5.0% from 2025 to 2035. This article explores the key trends, drivers, and future outlook of the plastic pipes market.
Get a…
More Releases for Pranlukast
Recombinant DNA Technology Market Poised to Grow from USD 774.12 Billion in 2024 …
The Recombinant DNA Technology Market is witnessing robust growth as biotechnology continues to reshape modern medicine, agriculture, and industrial processes. Recombinant DNA technology enables the modification and replication of genetic material to produce therapeutic proteins, vaccines, hormones, and enzymes with high precision and consistency. Its widespread application across pharmaceuticals, diagnostics, and research is positioning the market as a cornerstone of next-generation biological innovation.
As per MRFR analysis, the Recombinant DNA Technology…
Healthcare Consulting Services Market Growth Outlook: USD 73.6 Billion by 2035 W …
The Healthcare Consulting Services Market has emerged as a critical pillar supporting the transformation of global healthcare systems, reflecting the industry's increasing complexity, regulatory demands and technological evolution. As healthcare organizations navigate challenges including rising costs, workforce shortages, digital transformation imperatives and value-based care models, the demand for specialized consulting expertise continues to surge. From strategic planning and operational optimization to IT implementation, regulatory compliance and financial management, consulting services…
Hearing Aids Market Growth: Valued at USD 13.16 Billion in 2024, Expected to Hit …
Hearing Aids Market: Market Overview, Key Market Segments, Industry Latest News, Key Companies, Market Drivers, and Regional Insights
The global hearing aids market has witnessed steady growth over the past decade, driven by an increasing prevalence of hearing disorders, technological advancements in auditory devices, and a growing geriatric population. Hearing aids are electronic sound amplification devices designed to help individuals with hearing impairments by improving their hearing capabilities. The market has…
Medical Billing Market Growth Forecast Report 2032 | Advancements in AI, Cloud T …
Market Overview
The medical billing market is expected to witness significant growth through 2032, driven by the increasing demand for efficient billing solutions across healthcare sectors.
It is segmented by type into professional and institutional billing, catering to different service providers.
Applications span database management, financial operations, infrastructure, and operational functions, ensuring seamless billing processes.
Additionally, the market is influenced by the adoption of electronic billing, payment systems, and outsourced medical billing services, which…
Stretch Ceilings Market Size and Forecast
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Stretch Ceilings Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
The stretch ceilings market encompasses a wide array of products and services catering to the demand for flexible and aesthetically pleasing ceiling solutions. It includes…
Anti Asthma Drugs Market 2018; Leading Players Baxter International, Baxter Inte …
The Global Anti-Asthma Drugs Market has been segmented on the basis of drug class, route of administration, therapy, trigger, type, and lastly, region. On the basis of drug class, this market has been segmented into bronchodilators, corticosteroids, leukotriene antagonists, mast cell stabilizers, monoclonal antibody, and others. Bronchodilators have been further segmented into anticholinergics, beta agonists, and Xanthines.
Based on the route of administration, the market has been segmented into inhaled, intravenous,…
